Nutritional epigenomics of metabolic syndrome

被引:20
作者
Junien, C [1 ]
Gallou-Kabani, C [1 ]
Vigé, A [1 ]
Gross, MS [1 ]
机构
[1] INSERM, U383, Hop Necker Enfants Malades, F-75743 Paris, France
来源
M S-MEDECINE SCIENCES | 2005年 / 21卷 / 04期
关键词
D O I
10.1051/medsci/2005214396
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The importance of epigenetic alterations has been acknowledged in cancer for about two decades by an increasing number of molecular oncologists who contributed to deciphering the epigenetic codes and machinery and opened the road for a new generation of drugs now in clinical trials. However, the relevance of epigenetics to common diseases such as metabolic syndrome and cardiovascular disease was less conspicuous. This review focuses on converging data supporting the hypothesis that, in addition to << thrifty genotype >> inheritance, individuals with metabolic syndrome (MetS) - combining disturbances in glucose and insulin metabolism, excess of predominantly abdominally distributed weight, mild dyslipidemia and hypertension, with the subsequent development of obesity, type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD) have suffered improper << epigenetic programming >> during their fetal/postnatcil development due to maternal inadequate nutrition and metabolic disturbances and also during their lifetime. Moreover, as seen for obesity and T2D, MetS tends to appear earlier in childhood, to be more severe from generation to generation and to affect more pregnant women. Thus, in addition to maternal effects, MetS patients may display << transgenerational effects >> via the incomplete erasure of epigenetic marks endured by their parents and grandparents. We highlight the susceptibility of epigenetic mechanisms controlling gene expression to environmental influences due to their inherent malleability, emphasizing the participation of transposable elements and the potential role of imprinted genes during critical time windows in epigenetic programming, from the very beginning of development throughout life. Increasing our understanding on epigenetic patterns significance and small molecules (nutrients, drugs) that reverse epigenetic (in)activation should provide us with the means to << unlock >> silenced (enhanced) genes, and to << convert >> the obsolete human thrifty genotype into a << squandering >> phenotype.
引用
收藏
页码:396 / 404
页数:9
相关论文
共 33 条
  • [1] Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals?
    Armitage, JA
    Khan, IY
    Taylor, PD
    Nathanielsz, PW
    Poston, L
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 561 (02): : 355 - 377
  • [2] A rheostat model for a rapid and reversible form of imprinting-dependent evolution
    Beaudet, AL
    Jiang, YH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (06) : 1389 - 1397
  • [3] Endocrine pancreas development is altered in foetuses from rats previously showing intra-uterine growth retardation in response to malnutrition
    Blondeau, B
    Avril, I
    Duchene, B
    Bréant, B
    [J]. DIABETOLOGIA, 2002, 45 (03) : 394 - 401
  • [4] Resourceful imprinting
    Constäncia, M
    Kelsey, G
    Reik, W
    [J]. NATURE, 2004, 432 (7013) : 53 - 57
  • [5] Coadaptaition in mother and infant regulated by a paternally expressed imprinted gene
    Curley, JP
    Barton, S
    Surani, A
    Keverne, EB
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2004, 271 (1545) : 1303 - 1309
  • [6] Fat chance: genetic syndromes with obesity
    Delrue, MA
    Michaud, JL
    [J]. CLINICAL GENETICS, 2004, 66 (02) : 83 - 93
  • [7] Epigenetics in human disease and prospects for epigenetic therapy
    Egger, G
    Liang, GN
    Aparicio, A
    Jones, PA
    [J]. NATURE, 2004, 429 (6990) : 457 - 463
  • [8] The fat-brain axis enters a new dimension
    Elmquist, JK
    Flier, JS
    [J]. SCIENCE, 2004, 304 (5667) : 63 - 64
  • [9] Obesity, metabolic syndrome, and cardiovascular disease
    Grundy, SM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2595 - 2600
  • [10] DNA hypomethylation and methyltransferase expression in atherosclerotic lesions
    Hiltunen, M
    Turunen, MP
    Häkkinen, TP
    Rutanen, J
    Hedman, M
    Mäkinen, K
    Turunen, AM
    Aalto-Setälä, K
    Ylä-Herttuala, S
    [J]. VASCULAR MEDICINE, 2002, 7 (01) : 5 - 11